Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Wednesday, 6 December 2017, 16:34 HKT/SGT
Share:
    

Source: Sisram Medical Ltd
The New ALMA BEAUTY SPADEEP Platform Launched Globally After Receiving Outstanding Feedbacks in the Japanese Market

HONG KONG, Dec 6, 2017 - (ACN Newswire) - Sisram Medical Ltd ("Sisram" or the "Company"; stock code: 1696.HK), an investment holding company specializing in medical technology for healthcare, ranked #1 in the PRC and one of the top 5 global leaders in the industry, announces the global launch of the new ALMA BEAUTY SPADEEP platform, developed, manufactured and marketed by Alma Lasers Ltd. ("Alma Lasers"), its principal operating subsidiary.

ALMA BEAUTY SPADEEP, an advanced body contouring and skin rejuvenation solution, is a new non-invasive platform. The product was first launched in Japan by RITSUBI Co. Ltd., Alma Lasers partner, and received outstanding feedbacks including the "Best Beauty Item 2017" award by the "Esthetic Wired" magazine, the largest circulating B2B magazine in the Japanese esthetic industry.

ALMA BEAUTY SPADEEP utilizes concentrated thermal radiofrequency energy for body and face contouring, skin tightening and skin rejuvenation. This enhanced solution features multiple innovations, including 2 applicator connectors enabling ultimate flexibility and convenience for practitioners, next-generation depth control offering 4 levels of tissue depth penetration, safe and effective for all skin types, a 7" color screen and intuitive, user-friendly graphical user-interface (GUI), various pre-set treatment protocols and ergonomic applicator tips for enhanced results.

According to Medical Insight report, worldwide energy-based Body Shaping and Skin Tightening revenues of equipment and consumables were almost $1.0 billion in 2016. In 2016, 8.1 million energy-based Body Shaping and Skin Tightening procedures were performed worldwide - it is estimated that in 2016 that total consumer expenditure was $4.4 billion.

Mr. Lior M. Dayan, Chief Executive Officer and Executive Director of Sisram, said, "Sisram's strong R&D capabilities lay a solid foundation for the company's innovative technologies and new products. Sisram is focusing on meeting and exceeding the specific needs of treatment providers as well as end-users, as the Japanese award examples. I would like to thank our Japanese partners, RITSUBI Co. Ltd. for their contribution to the success of this product launch".

About Sisram Medical Ltd
Sisram Medical Ltd. (1696.HK), the first Israeli company listed on the Hong Kong Stock Exchange Main Board, is an investment holding company specializing in medical technology for healthcare. Among its holdings is Alma Lasers, a leading provider of energy-based surgical and medical aesthetic solutions, rating #1 in the Peoples Republic of China and one of the top 5 global leaders in its industry. Sisram Medical is a subsidiary of Fosun Pharma, a leading health & medical industry group in China.
Sisram Medical - Enhancing Quality of Life.
www.sisram-medical.com



Dec 6, 2017 16:34 HKT/SGT
Topic: Press release summary
Sectors: Daily Finance, HealthCare
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2017 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Sisram Medical Ltd
Nov 27, 2017 11:38 HKT/SGT
Sisram Medical Ltd Increase in Shareholding by Controlling Shareholder and CEO As a Vote of Confidence and Trust in the Company's Future Success
Sept 29, 2017 18:31 HKT/SGT
Sisram Med Revenue in First Half 2017 Increased 12.9% to US$66.3 Million
Sept 20, 2017 12:57 HKT/SGT
Net Proceeds of approximately HK$877.2 Million from Global Offering; Sisram Med Trading Debut on SEHK on 19 September 2017
Sept 20, 2017 12:34 HKT/SGT
Sisram Med Successfully Listed on Main Board of SEHK
Sept 5, 2017 17:00 HKT/SGT
Sisram Medical Offers price between HK$8.88 and HK$12.35 per share
More news >>
 News Alerts
Copyright © 2017 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 10 8405 3688 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 6721 7212

Connect With us: